Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Slower CDK4 and faster CDK2 activation in the cell cycle: Structure
Distinct allosteric networks in CDK4 and CDK6 in the cell cycle and in ...
CDK4 selective inhibition improves preclinical anti-tumor efficacy and ...
Molecular Pathways: CDK4 Inhibitors for Cancer Therapy | Clinical ...
CDK4 and CDK6 kinases: From basic science to cancer therapy | Science
Identification of CDK4 as a target of c-MYC | PNAS
Multistep activation of CDK4. CDK4 activation requires (i) increased ...
CDK4 protein is degraded by anaphase-promoting complex/cyclosome in ...
Cdk4 and Cdk6 Couple the Cell-Cycle Machinery to Cell Growth via mTORC1 ...
Requirement for CDK4 kinase function in breast cancer: Cancer Cell
Schematic diagram of cdk4 activation. The activity of cdk4 complexes is ...
CDK4 Cyclin dependent kinase 4
Crystal structure of human CDK4 in complex with a D-type cyclin ...
CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis ...
Genes & Cancer | CDK4: a master regulator of the cell cycle and its ...
Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor ...
Deciphering the Immunomodulatory Role of Cyclin-Dependent Kinase 4/6 ...
The Evolving Pathways of the Efficacy of and Resistance to CDK4/6 ...
Targeting Protein-Protein Interactions to Inhibit Cyclin-Dependent Kinases
The role of CDK4/6 in the cell cycle | Download Scientific Diagram
CDK4: Linking cell size to cell cycle control - PMC
The role of targeting CDK4/6 in cancer immunotherapy | Holistic ...
Frontiers | Breast Cancer Resistance to Cyclin-Dependent Kinases 4/6 ...
Under standard conditions CDK4/6, directed by upstream signaling ...
The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue ...
The Therapeutic Potential of CDK4/6 Inhibitors, Novel Cancer Drugs, in ...
CDK4/6 inhibitors induce breast cancer senescence with enhanced anti ...
CDK4/6 inhibitors: a brief overview and prospective research directions ...
Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers ...
CDK4/6 Inhibitor Resistance in Hormone Receptor-Positive Metastatic ...
Frontiers | CDK 4/6 inhibitors for the treatment of meningioma
CDK4/6 inhibition in breast cancer: current practice and future ...
Figure 1 from The Use of Cyclin-Dependent Tyrosine Kinase 4/6 (CDK4/6 ...
Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older ...
Cell cycle progression mechanisms: slower cyclin-D/CDK4 activation and ...
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i): Mechanisms of ...
Frontiers | CDK4/6 Inhibitors in Combination Therapies: Better in ...
Targeting cyclin-dependent kinases 4 and 6 in cancer - PMC
The Renaissance of CDK Inhibitors in Breast Cancer Therapy: An Update ...
CDK2 和 CDK4：细胞周期功能进化出独特的、具有催化能力的构象，提供药物靶点,JACS Au - X-MOL
CDK4/6抑制剂在乳腺癌治疗中耐药机制和改进策略--生命经纬
CDK4/6抑制剂在乳腺癌治疗中耐药机制和改进策略-MedSci.cn
Past, Present, and Future of CDK4/6-targeted Therapeutics | AACR
CDK4/6 inhibition in cancer: the cell cycle splicing connection - PMC
The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and ...
International Journal of Molecular Medicine
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with ...
Frontiers | Targeting cyclin-dependent kinases in sarcoma treatment ...
Sequential activation of E2F via Rb degradation and c-Myc drives ...
Frontiers | Mechanisms and Implications of CDK4/6 Inhibitors for the ...
Cell cycle on the crossroad of tumorigenesis and cancer therapy: Trends ...
[PDF] Molecular Pathways: Targeting the Cyclin D–CDK4/6 Axis for Cancer ...
Regulation of the cell cycle and cyclin-dependent kinase inhibitors in ...
Proposed model of Cdk4-p16Ink4a-regulated regeneration of β-cell mass ...
Long-term breast cancer response to CDK4/6 inhibition defined by TP53 ...
Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 ...
Clinique spécialisée Menara - ppt télécharger
CDK 4-6 inhibitors in management of carcinoma breast | PPTX
Development of CDK4/6 Inhibitors: A Five Years Update
Recent Progress in CDK4/6 Inhibitors and PROTACs
Double-Faced Immunological Effects of CDK4/6 Inhibitors on Cancer ...
Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− ...
The regulatory role of CDK4/6 inhibitors in tumor immunity and the ...
New Insights into CDK Regulators: Novel Opportunities for Cancer ...
The Strange Case of CDK4/6 Inhibitors: Mechanisms, Resistance, and ...
Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
The role of the cyclin D1–CDK4/6–RB pathway in breast cancer. The role ...
Mechanisms of resistance to CDK4/6 inhibitors. (1) Mechanisms related ...
The structure of CDK4/cyclin D3 has implications for models of CDK ...
Potential mechanisms of CDK4/6i resistance by CDK6 and chronic ...
Cell：组合使用CDK2抑制剂和CDK4/6抑制剂有望治疗抗药性乳腺癌 - 癌症研究专区 - 生物谷
CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges
Figure 1 from The Ongoing Search for Biomarkers of CDK4/6 Inhibitor ...
Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive ...
防早期荷爾蒙陽性乳癌復發！醫解CDK4/6抑制劑，助控復發、好好生活 | 蕃新聞
防早期荷爾蒙陽性乳癌復發！醫解CDK4/6抑制劑，助控復發、好好生活
Cell Cycle – Molecular Biology
CDK4/6 Inhibitors May Replace Chemotherapy in HR-Positive, HER2 ...
抗癌新贵-CDK4/6抑制剂-公司新闻-TargetMol中国
CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once ...
Cell division cycle. Four CYCLIN/Cdk kinase complexes control ...
Mechanism of CDK4/6 Inhibitor Resistance in Hormone Receptor-positive ...
Cyclin D-CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell ...
Figure 1 from Resistance to CDK4/6 Inhibitors in Estrogen Receptor ...
Cell cycle kinases as therapeutic targets for cancer | Nature Reviews ...
The regulators of CDK4/6 investigated in the context of gastric cancer ...
CDK4/6 inhibitor-mediated cell overgrowth triggers osmotic and ...
Diagram illustrating the role of cyclin D-dependent kinases (CDK4 ...
Endocrine therapy in metastatic breast cancer-more than just CDK4/6 ...
Detailed model for the Cdk network driving the mammalian cell cycle ...
CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest: Trends in Cell ...
Frontiers | CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
CDK4/6 Inhibitor Resistant Breast Cancer Models - WuXi Biology
